These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7233522)

  • 1. Hepatitis B due to transfusion of mislabeled blood.
    Seder RH; Chopra S; Schumacher R; Koff RS
    Transfusion; 1981; 21(3):363-5. PubMed ID: 7233522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
    Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
    Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group.
    Hoofnagle JH; Seeff LB; Bales ZB; Wright EC; Zimmerman HJ
    Ann Intern Med; 1979 Dec; 91(6):813-8. PubMed ID: 517881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.
    Allain JP; Hewitt PE; Tedder RS; Williamson LM
    Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of HBsAg, anti-HBs, the anti-CMV following the transfusion of blood products.
    Contreras TJ; Lang DJ; Pivacek LE; Valeri CR
    Transfusion; 1979; 19(2):129-36. PubMed ID: 219565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively.
    Hollinger FB; Dressman GR; Fields H; Melnick J
    Am J Med Sci; 1975; 270(2):343-8. PubMed ID: 1235476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
    Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
    Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.